Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 9(1): 5451, 2019 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-30931970

RESUMO

The present work is aimed at studying the dynamic behaviour of the tryptopnanase (tna) operon, which encodes the proteins necessary to uptake and metabolise tryptophan to use it as a carbon source in the absence of glucose. To this end, we designed a micro-bioreactor capable of driving a bacterial culture to a stationary state. This allowed us to explore (at the single cell level) the tna operon steady-state dynamics under multiple culture conditions. Our experimental results suggest that the tna operon is bistable for a specific range of environmental tryptophan and glucose concentrations, and evidence that both reagents play a role on the activation of the enzyme in charge of metabolising tryptophan: tryptophanase (TnaA). Based on our experimental data and the already known regulatory mechanisms, we developed a mathematical model for the tna operon regulatory pathway. Our modelling results reinforce the claim that the tna operon is bistable, and further suggest that the activity of enzyme TnaA is regulated by the environmental levels of glucose and tryptophan via a common signalling pathway. Possible biological implications of our findings are further discussed.


Assuntos
Proteínas de Escherichia coli/metabolismo , Escherichia coli/genética , Regulação Bacteriana da Expressão Gênica , Óperon , Processamento de Proteína Pós-Traducional , Triptofanase/metabolismo , Escherichia coli/enzimologia , Proteínas de Escherichia coli/genética , Transdução de Sinais , Triptofanase/genética
2.
Eur J Nutr ; 55(8): 2445-2458, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26410393

RESUMO

INTRODUCTION: During growth, protein deprivation impairs epiphyseal growth plate (EGP) height, bone volume (BV) and endochondral ossification. During catch-up growth, Ca availability becomes essential to ensure the extra amount needed to achieve optimal peak bone mass and strength. GOS and FOS improve mineral absorption in the colon. PURPOSE: The effect of a mixture of GOS/FOS® 9:1 added to a 0.5 %Ca (NCa) and a 0.3 %Ca (LCa) diets on Ca, P and Mg absorptions and bone mineralization, density and structure using an experimental model of growing rats recovering from early protein malnutrition was investigated. METHODS: To induce protein malnutrition, rats were fed a low protein diet: 4 % (LPD) during 1 week and then were randomly assigned to recovery groups (R) until day 50 (T = 50) as follows: R0.5 %: NCa; RP0.5 %: NCa + 5.3 % GOS/FOS®; R0.3 %: LCa and RP0.3 %: LCa + 5.3 % GOS/FOS®. Control groups received the 0.5 %Ca or 0.3 %Ca diet from weaning until day 40 or 50. RESULTS: Body weight and length increased in C groups throughout the study; both were arrested in all R during LPD consumption and increased immediately after re-feeding. Independently of dietary Ca content, LS counts, ß-glucosidase and Ca, P and Mg absorption increased, whereas cecum pH, ß-glucuronidase, urease and tryptophanase decreased in RP0.5 %: and RP0.3 %: as compared to the other studied groups (p < 0.01). Prebiotic consumption decreased CTX levels and increased femur Ca, Mg and P contents, total skeleton bone mineral content, proximal tibia and spine BMD, BV, EGP height and hypertrophic zone thickness, stiffness and elastic modulus as compared to recovery groups fed the prebiotic-free diets. CONCLUSION: Under the present experimental conditions, GOS/FOS® mixture induced colonic positive effects, which increased Ca, P and Mg absorption. Thus, consuming the prebiotic-containing diet resulted in an extra amount of minerals that improved bone development in growing rats recovering from protein malnutrition.


Assuntos
Cálcio da Dieta/farmacocinética , Oligossacarídeos/administração & dosagem , Desnutrição Proteico-Calórica/tratamento farmacológico , Trissacarídeos/administração & dosagem , Animais , Disponibilidade Biológica , Peso Corporal , Densidade Óssea/efeitos dos fármacos , Desenvolvimento Ósseo/efeitos dos fármacos , Calcificação Fisiológica/efeitos dos fármacos , Cálcio da Dieta/administração & dosagem , Cálcio da Dieta/sangue , Ceco/efeitos dos fármacos , Ceco/metabolismo , Dieta , Fezes/química , Fêmur/efeitos dos fármacos , Fêmur/fisiologia , Glucuronidase/metabolismo , Lâmina de Crescimento/efeitos dos fármacos , Lâmina de Crescimento/fisiologia , Absorção Intestinal , Magnésio/administração & dosagem , Magnésio/sangue , Magnésio/farmacocinética , Masculino , Oligossacarídeos/sangue , Oligossacarídeos/farmacocinética , Fósforo na Dieta/administração & dosagem , Fósforo na Dieta/sangue , Fósforo na Dieta/farmacocinética , Prebióticos/administração & dosagem , Desnutrição Proteico-Calórica/sangue , Ratos , Ratos Wistar , Trissacarídeos/sangue , Trissacarídeos/farmacocinética , Triptofanase/metabolismo , Urease/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA